Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

HIKMA
FDA Approves Unknown Drug — HIKMA

HIKMA Pharmaceuticals announced on Tuesday that the U.S. FDA approved its Abbreviated New Drug Application (ANDA 218728), signaling a positive pipelin...

Somerset
FDA Approves SUGAMMADEX — Somerset Therapeutics, LLC

Somerset Therapeutics has received FDA approval for the intravenous formulation of sugammadex, the antidote to rocuronium bromide, marking a pivotal e...

Hikma
FDA Approves SUGAMMADEX — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. announced on Friday the approval of sugammaDEX sodium for the intravenous treatment of hyperkalemia, securing a key FDA...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA INC

TEVA PHARMS USA INC announced the FDA approval of its ANDA application 214126, clearing the way for the launch of the generic version of the Blockbust...

Baxter
FDA Approves DIAZEPAM — Baxter Healthcare Corporation

Baxter Healthcare Corporation received marketing authorization for a generic Intramuscular Diazepam solution on July 28, 2026, introducing additional ...

MANKIND
FDA Approves Unknown Drug — MANKIND PHARMA

MANKIND PHARMA announced FDA approval for ANDA214230 on July 28, 2026, a decision expected to strategically expand its product portfolio and drive rev...

VIATRIS
FDA Approves Unknown Drug — VIATRIS SPECIALTY

VIATRIS SPECIALTY receives FDA approval for the New Drug Application 219990 on July 28, 2026, with significant market implications expected to drive p...

PAI
FDA Approves Unknown Drug — PAI HOLDINGS

PAI HOLDINGS announced the approval of its ANDA by the FDA for a new generic drug on July 28, setting the stage for imminent market entry and potentia...

Sun
FDA Approves SUGAMMADEX — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries announced Monday that the FDA has approved the ANDA for sugammadex sodium, expanding a strategic market opportunity with...

TMT
13F-HR - TMT General Partner Ltd (0001847582) (Filer)

Institutional holdings report (13F-HR) filed by TMT General Partner Ltd....

ProCore
13F-HR - ProCore Advisors, LLC (0002085963) (Filer)

Institutional holdings report (13F-HR) filed by ProCore Advisors, LLC....

TAIYO
13F-HR - TAIYO LIFE INSURANCE CO (0001254890) (Filer)

Institutional holdings report (13F-HR) filed by TAIYO LIFE INSURANCE CO....

Latitude
13F-HR - Latitude Advisors, LLC (0001843715) (Filer)

Institutional holdings report (13F-HR) filed by Latitude Advisors, LLC....

Strategic
13F-HR - Strategic Financial Concepts, LLC (0001870686) (Filer)

Institutional holdings report (13F-HR) filed by Strategic Financial Concepts, LLC....

Sellwood
13F-HR - Sellwood Investment Partners LLC (0001763958) (Filer)

Institutional holdings report (13F-HR) filed by Sellwood Investment Partners LLC....

ACUTE
13F-HR - ACUTE INVESTMENT ADVISORY, LLC (0001944780) (Filer)

Institutional holdings report (13F-HR) filed by ACUTE INVESTMENT ADVISORY, LLC....

NOVUS
13F-HR - NOVUS ADVISORS, LLC (0002042508) (Filer)

Institutional holdings report (13F-HR) filed by NOVUS ADVISORS, LLC....

Kure
13F-HR - Kure Advisory, LLC (0001986795) (Filer)

Institutional holdings report (13F-HR) filed by Kure Advisory, LLC....

JOHNSON
J&J Resolves Ovarian Talc Litigation Talks

After a favorable court ruling on specific causation, Johnson & Johnson is proposing a resolution to roughly 76,000 ovarian talc claims conditioned on...

Keen
KVAC amends charter to reflect status as merger sponsor

Keen Vision Acquisition Corp. filed an amended and restated charter as a merger sponsor. Market implications include clarified corporate governance fo...